Clinical Trial Update: X-linked Hypophosphatemia Disease Monitoring Program

View source ↗

Summary

Ultragenyx is conducting a disease monitoring program for X-linked hypophosphatemia and related hypophosphatemic rickets, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatemic Rickets
• X-linked Hypophosphatemia

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: X-linked Hypophosphatemia, Hypophosphatemic Rickets | Status: ACTIVE_NOT_RECRUITING